Seasonal flu is emerging as a major public health concern in India, with experts estimating that the infection is linked to nearly 1.2 lakh deaths every year.
India's Ebola support to African nations during the ongoing Ebola outbreak has brought renewed attention to a long-standing challenge facing the continent—its limited ability to produce vaccines locally.
Sun Pharma recall has once again brought attention to drug manufacturing standards and regulatory compliance in the United States.
India’s HPV campaign has reached a major milestone, with nearly 50 lakh girls vaccinated within just three months of the nationwide rollout.
The World Health Organization (WHO) has taken a major step toward improving child-focused dengue treatment with the publication of its first-ever Paediatric Drug Optimization Process (PADO) for dengue.
Centre mandates doctor prescriptions for cough syrups and syrup-based medicines, ending OTC sales and strengthening drug safety regulations nationwide.
US FDA flags quality lapses at an Indian drug plant, raising import scrutiny concerns and reinforcing the need for strict data integrity and global manufacturing compliance.
.jpeg)
Government may lift price cap on key cancer drugs like cisplatin and carboplatin, allowing up to 50% price hike amid raw material surge and supply shortage concerns.
Phox Health Revolutionizes Medicine Delivery in India as the US-based healthcare logistics company officially launches its India operations, marking a significant step in the country's evolving healthcare supply chain sector.
The Central Drugs Standard Control Organisation (CDSCO) has flagged several drug samples linked to some of India’s leading pharmaceutical companies as Not of Standard Quality (NSQ) for April 2026, highlighting ongoing concerns around drug quali...
.jpg)
, CDSCO.jpg)